Key result
Elevated left atrial stiffness index is linked to ~92% higher mortality in non-ischemic DCM.
Why the study?
Reliable predictors of adverse outcomes in non-ischemic dilated cardiomyopathy remain limited, motivating an evaluation of the prognostic value of the left atrial stiffness index beyond established left atrial and diastolic markers.
Does the echocardiographic left atrial stiffness index (LASI) predict all-cause mortality in patients with non-ischemic dilated cardiomyopathy?
Cohort (n=200)
No
Does the echocardiographic left atrial stiffness index (LASI) predict all-cause mortality in patients with non-ischemic dilated cardiomyopathy?
In patients with non-ischemic dilated cardiomyopathy, the echocardiographic left atrial stiffness index (LASI) independently predicts all-cause mortality beyond established markers like LAVi and E/e'.
Answers are grounded in this paper and cite their sources.
LASI may refine mortality risk stratification in non-ischemic dilated cardiomyopathy; hypothesis-generating and requires prospective validation before practice change.
AIMS: Reliable predictors of adverse outcomes in non-ischemic dilated cardiomyopathy (NIDCM) remain limited. We aimed to evaluate the association between the left atrial stiffness index (LASI) and all-cause mortality in patients with NIDCM and to assess its prognostic value beyond established left atrial and diastolic markers. METHODS: Retrospective analysis of a prospectively recruited cohort of patients diagnosed with NIDCM between 2018 and 2022. All patients underwent comprehensive transthoracic echocardiography at the time of diagnosis. Left atrial (LA) strain was measured retrospectively from stored baseline echocardiograms using two-dimensional speckle-tracking analysis, and LASI was calculated as the ratio of E/e' to LA reservoir strain. Multivariable analyses were performed to identify variables independently associated with all-cause mortality. RESULTS: Among 200 patients (mean age 61.7 years; 40% women), 33 (16.5%) died over a median follow-up of 43.8 months. In multivariable Cox regression analysis, variables independently associated with all-cause mortality were LASI (adjusted hazard ratio [HR] 1.92, 95% confidence interval [CI] 1.33-2.77), age (HR 1.05, 95% CI 1.02-1.08) and right ventricular-pulmonary artery (RV-PA) coupling index (HR 0.25, 95% CI 0.07-0.89); the model showed good discrimination (optimism-corrected C-index 0.766). LASI remained independently associated with mortality when modeled together with left atrial volume index (LAVi) and with E/e'. CONCLUSION: In NIDCM, LASI provides prognostic information for all-cause mortality beyond other morphological and functional LA markers. Given the single-center design and the limited number of events, these findings warrant external validation.
No takes yet. Share an insight, caveat, or question.
Sanchez et al. (2026) conducted a cohort in Non-ischemic dilated cardiomyopathy (NIDCM) (n=200). Left atrial stiffness index (LASI) vs. Established left atrial and diastolic markers (left atrial volume index [LAVi] and E/e') was evaluated on All-cause mortality (HR 1.92, 95% CI 1.33-2.77). Left atrial stiffness index (LASI) was independently associated with all-cause mortality in non-ischemic dilated cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: